Pharmaceutical Industry Articles & Reports - Page 29

Explore 2025 data on AI adoption in private medical practices. Learn how AI tools for administrative tasks reduce burnout and see key stats on usage and gaps.

Analyze the 2025 AI engineer job market. Learn the core responsibilities, average salary, and how the role differs from a data scientist or ML engineer.

A technical overview of Claude Opus 4.5 and 4.6, state-of-the-art AI models for coding. Learn their capabilities for software development in healthcare and pharma. Updated February 2026.

Comprehensive guide to the EU Falsified Medicines Directive (FMD) and global pharma serialization. Covers DSCSA 2025 enforcement, EMVS verification, GS1 barcodes, track-and-trace compliance, and 78+ country mandates.

Explore how GenAI helps manage pharmaceutical labeling in 2026. Learn to draft local label deviations from a CCDS using AI tools like Veeva AI Agents, and understand FDA-EMA guidance on AI in regulatory compliance.

Who owns pharmaceutical proofreading? Updated for 2026 with EU ePI mandates, DSCSA enforcement, Veralto-GlobalVision acquisition, and AI-augmented labeling workflows across artwork, regulatory, and QA teams.

Learn the end-to-end pharmacovigilance process for translating safety signals into drug label updates. Covers CCDS, Vault Signal, EU Regulation 2025/1466, FDA AEMS, and how modern PV platforms accelerate the safety-to-label relay. Updated April 2026.

Explore the career path from a Regulatory Affairs Generalist to a specialized Labeling Strategist. Learn key skills, role differences, salary data, and 2026 industry trends including mandatory EU ePI and digital labeling.

A comprehensive guide to the Target Product Profile (TPP) for drug development, updated for 2026. Learn TPP components, FDA and ICH guidance, IQVIA adoption data, and how to align your TPP with the final drug label.

Learn how Veeva RIM automates end-to-end pharmaceutical labeling. This guide explains 5 core workflows for label change management and regulatory compliance, updated with 2025–2026 platform enhancements, AI Agents roadmap, and EU ePI developments.

Get a 6-month checklist for pharmaceutical labeling operations. Updated for 2026 with DSCSA enforcement deadlines, FDA PMI rule status, EU ePI developments, and current recall data.

Learn how Veeva PromoMats' Auto-Update Anchors and new AI Agents automate marketing claims substantiation to ensure regulatory compliance and reduce manual MLR review effort. Updated for 2026 with latest Veeva AI capabilities and FDA/FTC enforcement trends.

Updated 2026 guide to Structured Product Labeling (SPL) and data integrity. Covers FDA mandates, EMA ePI roadmap, Health Canada XML-PM, FHIR standards, and ALCOA+ compliance for pharmaceutical labeling.

A guide to Reference Safety Information (RSI) in clinical trials. Learn the regulatory framework including ICH E6(R3), EU CTIS, and UK 2026 CT Regulations, common pitfalls, and how to avoid SUSAR reporting errors.

Explore the regulatory process for negotiating an FDA boxed warning on drug labeling, from initial NDA review to post-market Safety Labeling Changes (SLCs), with 2025-2026 case studies including HRT warning removal, Elevidys, Carvykti, and COVID vaccine labeling debates.

Learn to write the Highlights of Prescribing Information (HPI). Updated for 2026 with AI labeling tools, the Prescription Information Modernization Act, and generic drug labeling reforms. Covers FDA requirements, PLR, and best practices.

Learn how the FDA's PLLR replaced old pregnancy categories. Updated 2026 guide on drafting clear pregnancy risk summaries for biologics, with ICH E21, IMPACT trial, and PIANO registry data.

This comprehensive 2025 guide details e-labeling (e-IFU) regulations worldwide. See our country-by-country analysis of QR code acceptance for medical devices &

An evidence-based review of NLP in regulatory labeling (updated April 2026). Learn how AI assists medical writers in drafting Prescribing Information (PI/SmPC), including FDA Elsa, FDA-EMA joint AI principles, and current limitations.

A comprehensive guide to transitioning from XML-based SPL to HL7 FHIR for e-labeling. Updated for 2026 with EMA go-live timeline, Jordan mandate enforcement, FDA PQ/CMC STU2, and latest FHIR adoption data.

Updated 2026 guide to FDA off-label promotion regulations for MSL teams, covering the January 2025 SIUU guidance, September 2025 OPDP enforcement surge, USPI boundaries, and compliance best practices

Learn how pharmaceutical translation errors in SmPCs and patient leaflets lead to drug recalls, regulatory sanctions, and patient safety risks. Updated with 2025-2026 EU pharma legislation reform, EMA ePI roadmap, and AI translation developments.

Explore a structured cascade model for rolling out pharma safety labeling updates to global affiliates, covering FDA 505(o)(4) guidance, EMA variations framework, AI-powered PV tools, and sub-90-day implementation strategies.

Updated April 2026 analysis of Google's Gemini 3/3.1 Pro AI for healthcare, pharma, and biotech. Covers MedGemma 1.5, HIMSS 2026 deployments, Isomorphic Labs trials, and FDA/EU regulatory developments.